• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非诺贝特在十二烷基硫酸钠溶液中的溶解及溶解性行为

Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions.

作者信息

Granero Gladys E, Ramachandran Chandrasekharan, Amidon Gordon L

机构信息

College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Drug Dev Ind Pharm. 2005 Oct;31(9):917-22. doi: 10.1080/03639040500272108.

DOI:10.1080/03639040500272108
PMID:16306004
Abstract

The solubility of fenofibrate in pH 6.8 McIlvaine buffers containing varying concentrations of sodium lauryl sulfate was determined. The dissolution behavior of fenofibrate was also examined in the same solutions with rotating disk experiments. It was observed that the enhancement in intrinsic dissolution rate was approximately 500-fold and the enhancement in solubility was approximately 2000-fold in a pH 6.8 buffer containing 2% (w/v) sodium lauryl sulfate compared to that in buffer alone. The micellar solubilization equilibrium coefficient (k*) was estimated from the solubility data and found to be 30884+/-213 L/mol. The diffusivity for the free solute, 7.15x10(-6) cm2/s, was calculated using Schroeder's additive molal volume estimates and Hayduk-Laurie correlation. The diffusivity of the drug-loaded micelle, estimated from the experimental solubility and dissolution data and the calculated value for free solute diffusivity, was 0.86x10(-6) cm2/s. Thus, the much lower enhancement in dissolution of fenofibrate compared to its enhancement in solubility in surfactant solutions appears to be consistent with the contribution to the total transport due to enhanced micellar solubilization as well as a large decrease (approximately 8-fold) in the diffusivity of the drug-loaded micelle.

摘要

测定了非诺贝特在含有不同浓度月桂基硫酸钠的pH 6.8 McIlvaine缓冲液中的溶解度。还通过旋转圆盘实验在相同溶液中研究了非诺贝特的溶解行为。观察到,与仅含缓冲液相比,在含有2%(w/v)月桂基硫酸钠的pH 6.8缓冲液中,固有溶解速率提高了约500倍,溶解度提高了约2000倍。根据溶解度数据估算了胶束增溶平衡系数(k*),发现其为30884±213 L/mol。使用施罗德加和摩尔体积估计值和海杜克 - 劳里相关性计算了游离溶质的扩散系数,为7.15×10⁻⁶ cm²/s。根据实验溶解度和溶解数据以及计算得到的游离溶质扩散系数值估算出载药胶束的扩散系数为0.86×10⁻⁶ cm²/s。因此,与非诺贝特在表面活性剂溶液中溶解度的提高相比,其溶解的提高幅度要低得多,这似乎与胶束增溶增强对总传输的贡献以及载药胶束扩散系数大幅降低(约8倍)相一致。

相似文献

1
Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions.非诺贝特在十二烷基硫酸钠溶液中的溶解及溶解性行为
Drug Dev Ind Pharm. 2005 Oct;31(9):917-22. doi: 10.1080/03639040500272108.
2
Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine.药物在胶束溶液中的溶解:对流扩散模型的建立及其与膜平衡模型的比较,并应用于表面活性剂促进的卡马西平溶解
J Pharm Sci. 1996 Sep;85(9):1005-11. doi: 10.1021/js930336p.
3
Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant.难溶性弱酸酮洛芬的增溶与溶解:pH值与表面活性剂的联合作用
Eur J Pharm Sci. 2006 Nov;29(3-4):306-14. doi: 10.1016/j.ejps.2006.06.006. Epub 2006 Jun 27.
4
Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.探针超声法制备非诺贝特纳米晶体以提高溶出速率和口服生物利用度。
Colloids Surf B Biointerfaces. 2013 Aug 1;108:366-73. doi: 10.1016/j.colsurfb.2013.02.043. Epub 2013 Mar 23.
5
Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion.聚合物/表面活性剂载体对非诺贝特固体分散体溶解度和溶出度的影响。
AAPS PharmSciTech. 2019 Feb 5;20(3):102. doi: 10.1208/s12249-018-1273-z.
6
Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant.可电离水不溶性药物的溶出:pH值与表面活性剂的联合作用
J Pharm Sci. 2000 Feb;89(2):268-74. doi: 10.1002/(SICI)1520-6017(200002)89:2<268::AID-JPS14>3.0.CO;2-F.
7
Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate.水不溶性药物体外测试的溶出介质:表面活性剂纯度和电解质对卡马西平在十二烷基硫酸钠水溶液中体外溶出的影响
J Pharm Sci. 1997 Mar;86(3):384-8. doi: 10.1021/js960105t.
8
Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.表面活性剂介导的溶解:溶解度增强和相对较低的胶束扩散率的作用。
J Pharm Sci. 2004 Aug;93(8):2064-75. doi: 10.1002/jps.20118.
9
Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate.用于提高非诺贝特溶解速率的固体自乳化药物递送系统(S-SEDDS)
J Microencapsul. 2014;31(3):293-8. doi: 10.3109/02652048.2013.843601. Epub 2013 Oct 24.
10
A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.在层流条件下灰黄霉素在表面活性剂溶液中溶解的机理研究。
J Pharm Sci. 1997 Oct;86(10):1132-7. doi: 10.1021/js9604974.

引用本文的文献

1
Liquisolid Technique for Solubility Enhancement of Poorly Soluble Drug - A Brief Review.固体分散技术用于提高难溶性药物溶解度——简要综述
Curr Drug Discov Technol. 2024 Oct 4. doi: 10.2174/0115701638318659240923074614.
2
Impact of Additives on Drug Particles during Liquid Antisolvent Crystallization and Subsequent Freeze-Drying.液体抗溶剂结晶及后续冷冻干燥过程中添加剂对药物颗粒的影响
Org Process Res Dev. 2023 Oct 6;27(11):2020-2034. doi: 10.1021/acs.oprd.3c00204. eCollection 2023 Nov 17.
3
Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders.
非诺贝特-辛伐他汀固体分散体在开发用于治疗脂质紊乱的固定剂量制剂中的筛选。
Pharmaceutics. 2023 Feb 10;15(2):603. doi: 10.3390/pharmaceutics15020603.
4
Ternary Eutectic Ezetimibe-Simvastatin-Fenofibrate System and the Physical Stability of Its Amorphous Form.三元共晶ezetimibe-辛伐他汀-非诺贝特系统及其无定形形式的物理稳定性。
Mol Pharm. 2021 Sep 6;18(9):3588-3600. doi: 10.1021/acs.molpharmaceut.1c00485. Epub 2021 Aug 22.
5
Porous Nanostructure, Lipid Composition, and Degree of Drug Supersaturation Modulate In Vitro Fenofibrate Solubilization in Silica-Lipid Hybrids.多孔纳米结构、脂质组成和药物过饱和度程度调节非诺贝特在二氧化硅-脂质杂化物中的体外溶解。
Pharmaceutics. 2020 Jul 21;12(7):687. doi: 10.3390/pharmaceutics12070687.
6
Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate.非诺贝特脂质基液晶制剂的制备与评价
Adv Biomed Res. 2018 Sep 21;7:126. doi: 10.4103/abr.abr_188_17. eCollection 2018.
7
Physiologically Based Absorption Modeling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of Alectinib.基于生理的吸收建模以探究食物和胃内pH值变化对阿来替尼药代动力学的影响。
AAPS J. 2016 Nov;18(6):1464-1474. doi: 10.1208/s12248-016-9957-3. Epub 2016 Jul 22.
8
Assessment of Age-Related Changes in Pediatric Gastrointestinal Solubility.小儿胃肠道溶解度与年龄相关变化的评估
Pharm Res. 2016 Jan;33(1):52-71. doi: 10.1007/s11095-015-1762-7. Epub 2015 Jul 29.